AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Sirnaomics Secures $105 Million In Series E Financing

Jul 01, 2021•about 4 years ago

Amount Raised

$105 Million

Round Type

series e

Gaithersburg

Description

Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it has sealed $105 million in a Series E financing. This round of funding was led by Rotating Boulder Fund, an investor that has been supporting the company since its Series B round, with participation from existing investors and a well-recognized syndicate of new investors.

Company News

(9 articles)

Tue, 02 Feb 2021 08:00:00 GMT

Sirnaomics to Present at Medical Dermatology Summit - The Herald-Mail

Tue, 20 Jun 2023 07:00:00 GMT

Sirnaomics advances siRNA skin cancer candidate to late-stage trials - BioWorld MedTech

Thu, 30 Dec 2021 08:00:00 GMT

Sirnaomics Ltd., the RNA Therapeutics Biopharmaceutical Company with Strong Presence in Both US and China, Successfully Listed on Main Board of SEHK - BioSpace

Wed, 21 Apr 2021 07:00:00 GMT

Sirnaomics' Spin-Off RNAimmune Secures $10 Million Seed Financing to Advance its mRNA-Based Vaccine and Therapeutic Development - PR Newswire

Mon, 27 Jan 2020 08:00:00 GMT

Coronavirus: China tests AbbVie’s HIV drugs; Sirnaomics to develop drugs - Pharmaceutical Technology

Fri, 11 Jan 2019 08:00:00 GMT

Gaithersburg biopharma raises another $11M - The Business Journals

Wed, 17 Jun 2020 07:00:00 GMT

Sirnaomics and Precision NanoSystems Have Formed a Partnership - PR Newswire Canada

Thu, 07 Jun 2018 07:00:00 GMT

Gaithersburg biopharma company Sirnaomics raises $25M - The Business Journals

Wed, 05 Jul 2023 07:00:00 GMT

EDIRNA, Inc. announces establishment of Executive Team and Strategic Partnership with a Global RNA Biopharmaceutical Company - PR Newswire

FundzWatch™ Score

Medium Activity

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech